Abstract | BACKGROUND: METHODS: Intrathecal morphine at 0.3 μg/kg (LMPC), 3 μg/kg ( MMPC) or 30 μg/kg (HMPC) was administered for 5 min before 120-min reperfusion following 30-min ischemia. Infarct size as a percentage of area at risk (IS/AAR) was determined using triphenyltetrazolium staining. MMPC was repeated following the intrathecal administration of nor BNI, NTD, CTOP, or naloxone methiodide (NM), kappa, delta, mu and non-specific opioid receptor antagonists, respectively. The role of peripheral opioid, adenosine and calcitonin gene-related peptide ( CGRP) receptors was examined by the intravenous administration of NM, 8-ρ-sulfophenyl theophylline (8-SPT) and human CGRP fragment (CGRP(8-37)), respectively. RESULTS:
Morphine post-conditioning at all three doses was cardioprotective (IS/AAR of LMPC=37 ± 4%, MMPC=35 ± 5%, HMPC=32 ± 4%, control=50 ± 5%, P<0.01). The prior administration of opioid receptor antagonists intrathecally, as well as intravenous 8-SPT and CGRP(8-37) receptor antagonists, abolished this effect (nor BNI+MMPC=47 ± 7%, NTD+MMPC=49 ± 7%, CTOP+MMPC=45 ± 9%, NM+MMPC=47 ± 6% 8-SPT+MPC=46 ± 5% & CGRP(8-37)+MPC=53 ± 6%, P=0.63). However, the intravenous administration of NM did not prevent the protective effect (34 ± 4%, P<0.01). CONCLUSIONS:
|
Authors | J Ling Ling, G T C Wong, L Yao, Z Xia, M G Irwin |
Journal | Acta anaesthesiologica Scandinavica
(Acta Anaesthesiol Scand)
Vol. 54
Issue 9
Pg. 1097-104
(Oct 2010)
ISSN: 1399-6576 [Electronic] England |
PMID | 20887411
(Publication Type: Journal Article)
|
Chemical References |
- Analgesics, Opioid
- Receptors, Opioid
- Morphine
|
Topics |
- Analgesics, Opioid
(administration & dosage)
- Animals
- Injections, Spinal
- Ischemic Postconditioning
(methods)
- Morphine
(administration & dosage)
- Myocardial Infarction
(drug therapy)
- Myocardial Reperfusion Injury
(prevention & control)
- Rats
- Rats, Sprague-Dawley
- Receptors, Opioid
(drug effects, physiology)
|